A home care nurse administers oral morphine to the patient with cancer pain.
When will the nurse expect the medication to reach peak activity?
45 minutes.
10 minutes.
30 minutes.
60 minutes.
The Correct Answer is A
Choice A rationale
Oral morphine typically reaches peak activity at around 45 minutes after administration. This allows time for the medication to be absorbed through the gastrointestinal tract and enter the bloodstream to provide pain relief.
Choice B rationale
10 minutes is too short for oral morphine to reach peak activity. This timeframe is more consistent with intravenous administration, which allows for rapid onset of action.
Choice C rationale
30 minutes is a bit too short for oral morphine to reach peak effect, although some patients may start to feel relief. However, peak plasma concentrations generally occur closer to 45-60 minutes.
Choice D rationale
While morphine can continue to have effects up to 60 minutes and beyond, the peak activity is typically observed around the 45-minute mark. Waiting for 60 minutes may underestimate the peak timeframe.
Nursing Test Bank
Naxlex Comprehensive Predictor Exams
Related Questions
Correct Answer is A
Explanation
Choice A rationale
Assessing pulses and blood pressure is crucial before administering an antiarrhythmic agent because these drugs can affect heart rate and blood pressure, requiring close monitoring to prevent adverse effects.
Choice B rationale
While assessing breath sounds is important in overall patient care, it is not the priority before administering antiarrhythmic agents as these drugs primarily affect the cardiovascular system.
Choice C rationale
Assessing mental status is important in patient care, but it is not the priority before administering an antiarrhythmic agent, as these medications primarily influence cardiovascular parameters.
Choice D rationale
Assessing urine output is vital for monitoring kidney function and fluid balance, but it is not the priority before administering an antiarrhythmic agent, which mainly affects heart rhythm and blood pressure.
Correct Answer is B
Explanation
Choice A rationale
Glycopyrrolate is an anticholinergic medication that reduces secretions in the mouth, throat, and airways but is not typically used for bronchospasm associated with COPD.
Choice B rationale
Ipratropium is an anticholinergic bronchodilator that is commonly used to treat bronchospasm associated with COPD. It works by relaxing the muscles around the airways to improve breathing.
Choice C rationale
Atropine is an anticholinergic medication used to treat bradycardia and reduce secretions but is not indicated for bronchospasm associated with COPD.
Choice D rationale
Flavoxate is a urinary antispasmodic used to relieve symptoms of bladder spasms but has no role in the treatment of bronchospasm associated with COPD.
Whether you are a student looking to ace your exams or a practicing nurse seeking to enhance your expertise , our nursing education contents will empower you with the confidence and competence to make a difference in the lives of patients and become a respected leader in the healthcare field.
Visit Naxlex, invest in your future and unlock endless possibilities with our unparalleled nursing education contents today
Report Wrong Answer on the Current Question
Do you disagree with the answer? If yes, what is your expected answer? Explain.
Kindly be descriptive with the issue you are facing.